-
Hungary's PM-elect Magyar offers to meet Ukraine's Zelensky in June
-
Man pleads guilty to plotting attack on Taylor Swift concert
-
New pirate group behind latest Somali hijacking: officials
-
Swiss court dismisses corruption case against late Uzbek leader's daughter
-
Frenchman Godon wins Romandie prologue, Pogacar fifth
-
Trump hails British as 'friends' as king visits amid Iran tensions
-
Will fuel shortages ruin summer vacations?
-
Peace efforts stall as US examines latest Iran proposal
-
Mali faces advancing rebels in 'difficult' situation
-
Monk ends barefoot Sri Lanka trek with a dog and plea for peace
-
Macron urges Andorra to 'move forwards' on decriminalising abortion
-
German bid to rescue 'Timmy' the whale passes key hurdle
-
US Fed expected to keep rates steady as Iran war effects ripple
-
UAE pulls out of OPEC oil cartels citing 'national interests'
-
Crude back above $110 on Strait stalemate fears
-
Banking giant JP Morgan becomes Olympics sponsor
-
Emotional Stones announces Man City exit after golden decade
-
Jazz legend John Coltrane's son hits the high notes
-
John Stones to leave Manchester City after 10 years
-
Croatia, Bosnia sign major gas pipeline deal
-
Champions League semi-final like a first date: Atletico's Koke
-
Sinner queries schedule, surges into Madrid Open quarters
-
ICC orders $8.5mn compensation for victims of Malian war criminal
-
EU parliament adopts new rules to protect cats, dogs
-
EU lawmakers back blockbuster long-term budget
-
German rescuers launch new bid to free stranded whale
-
Man pleads guilty in Austria to plotting attack on Taylor Swift concert
-
Climbers open Everest route past dangerous ice block
-
Indian billionaire's son offers home for Escobar's hippos
-
Iranian Vafaei capable of great things, says beaten rival Trump
-
Comedian Kimmel hits back at criticism over Melania Trump joke
-
Man goes on trial in Austria over Taylor Swift concert attack plan
-
South Korean court increases ex-first lady's graft sentence
-
Bullying claims 'nonsense', actress Rebel Wilson tells Sydney court
-
BP reports huge profit rise in first quarter
-
Crude extends gains, stocks drop as Trump considers latest Iran proposal
-
How China block of AI deal could stop 'Singapore-washing'
-
North Korean executions rose dramatically during Covid: report
-
Budget airlines first to cut flights as jet fuel prices soar
-
Simeone, Atletico chasing redemption against Arsenal
-
'Bring it on', says Rice as Arsenal chase Champions League history
-
US says examining latest Iran proposal
-
S. Korea probes syringe hoarding as war hits plastic makers
-
Australia aims to tax tech giants unless they pay news outlets
-
Bangladesh's tigers stalk uncertain future in Sundarbans
-
Horses unlikely saviours for those who serve in uniform
-
Crude extends gains as Trump considers latest Iran proposal
-
Nations to kick off world-first fossil fuel exit talks
-
Philippine museum brings deadly, lucrative galleon trade to life
-
Opening remarks Tuesday in Elon Musk versus OpenAI
Indica Labs Joins the AWS Partner Network
Indica Labs, the global leader in AI-powered digital pathology software and services, announced today that they have joined the Amazon Web Services (AWS) Partner Network (APN). The APN is a global community of AWS Partners that leverage programs, expertise, and resources to build, market, and co-sell customer offerings. With the successful completion of the foundational technical review of HALO®, HALO AI, HALO Link, and HALO AP®, these platforms are now AWS Qualified Software. Customers now have confidence that the cloud architecture utilized by Cloud Services for life sciences and clinical deployments is validated by AWS.
"Indica Labs is honored to join the APN," said Eric Runde, Chief Operating Officer, Indica Labs. "AWS has long been recognized as the leading cloud services provider and it is an honor to meet their rigid standards and bring their technical advantages to customers of Indica Labs."
In addition to confidence in the security, performance, and scalability of HALO deployments, an optimized cloud deployment can lead to significant cost savings for customers. In a recent Cloud Services deployment of HALO®, HALO AI, and HALO Link software at the University of Washington BioRepository and Integrated Neuropathology (BRaIN) laboratory, a Cloud Services managed AWS deployment led to a 40% reduction in AWS cost in four months. Dr. C. Dirk Keene, Professor, University of Washington Department of Laboratory Medicine and Pathology Leader, commented, "Moving our HALO deployments to the cloud with Cloud Services has decreased monthly costs substantially and has allowed us to easily collaborate with other research institutions across the country."
The Cloud Services team is comprised of AWS Certified Solution Architects who have deep subject matter expertise in HALO deployments and are experienced with performing data migrations and facilitating custom integrations. Cloud Services customers maintain full ownership over their AWS account while Cloud Services manages all technical aspects of implementation and ongoing maintenance to deliver a highly performant and scalable HALO environment.
As an APN member, Indica Labs joins a global network of 130,000 Partners from more than 200 countries working with AWS to provide innovative solutions, solve technical challenges, win deals, and deliver value to mutual customers.
For more information, visit https://indicalab.com/cloud-services/ and https://aws.amazon.com/partners/.
HALO AP® is CE-IVDR marked for in-vitro diagnostic use in Europe, the UK, and Switzerland. HALO AP® is For Research Use Only in the USA and is not FDA cleared for clinical diagnostic use. In addition, HALO AP® provides built-in compliance with FDA 21 CFR Part 11, HIPAA, and GDPR.
About Indica Labs: Indica Labs is the global leader in AI-powered digital pathology software and services. Our flagship HALO® and HALO AI platform revolutionizes quantitative evaluation of whole slide images. HALO Link provides collaborative image management while HALO AP® and HALO AP Dx deliver enterprise digital pathology for primary diagnosis with regulatory clearances in multiple markets. Through a commitment to open pathology, performance, scalability, and ease-of-use, we help pharma companies, diagnostic labs, hospitals, research organizations, and Indica's own Cloud and Pharma Services make discoveries and diagnoses that transform patient care and scientific discovery.
Media Contact:
Eric Runde
[email protected]
SOURCE: Indica Labs
F.Pedersen--AMWN